FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Provectus Biopharmaceuticals Will Present at 8th Annual European Life Science CEO Forum & Exhibition
February 18, 2015
Provectus Biopharmaceuticals Analyst Report: A New Front against Cancer Issued by Small Cap IR
January 12, 2015
from PR Newswire
Provectus Biopharmaceuticals Will Present at 17th Annual BIO CEO And Investor Conference Tuesday, February 10, 2015
February 10, 2015
Provectus Biopharmaceuticals Met with FDA on Operational Aspects of PV-10 Phase 3 Melanoma Study
February 09, 2015
Provectus Biopharmaceutical’s PV-10 Featured in Article by Sanjiv Agarwala in Current Opinion in Oncology
February 06, 2015
Provectus Biopharmaceuticals Begins Recruitment for Phase 2 Mechanism of Action Clinical Trial Of PH-10 For Psoriasis
January 29, 2015
Provectus Biopharmaceuticals’ Novel Synthesis Patent Application Allowed by Chinese Patent Office
January 26, 2015
CORRECTING and REPLACING Provectus Biopharmaceuticals’ Protocol for Phase 2 Study of Mechanism of Action of PH-10 on Immunologic Markers of Psoriasis Now Available Online
December 23, 2014
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here